title: Pharmacological and molecular discrimination of brain I2-imidazoline receptor subtypes.
abstract: I2-imidazoline receptors labelled with [3H]-idazoxan in the rabbit and rat brains displayed high and low affinity, respectively, for the guanidide amiloride; reinforcing the previous definition of I2A-imidazoline receptors expressed in the rabbit brain and I2B-imidazoline receptors expressed in the rat brain. Other drugs tested displayed biphasic curves in competition experiments, indicating the existence of high and low affinity sites for both subtypes of I2-imidazoline receptors. Among the drugs studied, bromoxidine, moxonidine, (+)- and (-)-medetomidine and clorgyline were more potent on the high and/or low affinity sites of I2B-than on their corresponding of I2A-imidazoline receptors (KiH ratios 20 to 65). No correlation was found for the potencies of the drugs tested at the low affinity sites of both I2-imidazoline receptor subtypes. Preincubation (30 min at 25 degrees C) with 10(-6) M clorgyline reduced by 60% the Bmax of [3H]-idazoxan binding to I2B-imidazoline receptors in the rat brain, but it did not affect the binding parameters of the radioligand saturation curves to I2A-imidazoline receptors in the rabbit brain. These results indicated that I2A- and I2B-imidazoline receptor subtypes differ in the pharmacological profiles of their high and low affinity sites and in the ability to irreversibly bind clorgyline. In rat cortical membranes western blot detection of immunoreactive imidazoline receptors proteins revealed a double band of approximately 29/30 kDa and two less intense bands of approximately 45 and approximately 66 kDa. In rabbit cortical membranes the antibody used detected proteins of approximately 30, approximately 57 and approximately 66 kDa. It is suggested that different imidazoline receptor proteins (approximately 45 vs approximately 57 kDa) may account for the different pharmacological profiles of I2-imidazoline receptor subtypes.
authors.affiliation: Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.
authors.forename: G
authors.initials: G
authors.lastname: Olmos
authors.forename: R
authors.initials: R
authors.lastname: Alemany
authors.forename: J A
authors.initials: JA
authors.lastname: García-Sevilla
mesh_terms: D000818:Animals; D003010:Clorgyline / Q000494:pharmacology; D019329:Idazoxan / Q000378:metabolism; D054755:Imidazoline Receptors; D008297:Male; D008970:Molecular Weight; D008995:Monoamine Oxidase / Q000276:immunology; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D011955:Receptors, Drug / Q000145:classification* / Q000187:drug effects / Q000276:immunology; D013237:Stereoisomerism
chemical_list: D054755:Imidazoline Receptors; D011955:Receptors, Drug; D008995:Monoamine Oxidase; D003010:Clorgyline; D019329:Idazoxan